Physician profile
Eric E Chew
NPI 1104972462
$1,935.38
in general payments reported to CMS, 2019-2025
14 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $663 · 2022: $326 · 2023: $414 · 2024: $203 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $547.94 | 2021-2025 | Ozempic, Wegovy |
| Medtronic, INC. | $476.59 | 2021-2025 | Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $334.52 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $211.92 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $123.68 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $39.19 | 2023 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $38.19 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $28.83 | 2025 | Winrevair |
| Abbott Laboratories | $24.74 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.63 | 2023 | Jardiance |
| Astellas Pharma US INC | $22.83 | 2021 | |
| Preventice Services, LLC | $21.98 | 2021 | |
| Scpharmaceuticals INC. | $20.78 | 2023 | |
| Glaxosmithkline, LLC. | $20.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.